ARDELYX, INC. Logo

ARDELYX, INC.

Biopharmaceutical company developing medicines for cardiorenal and gastrointestinal diseases.

ARDX | US

Overview

Corporate Details

ISIN(s):
US0396971071
LEI:
Country:
United States of America
Address:
34175 ARDENWOOD BLVD., 94555 FREMONT

Description

Ardelyx, Inc. is a biopharmaceutical company that discovers, develops, and commercializes first-in-class medicines to address unmet medical needs. The company's primary therapeutic areas of focus are cardiorenal and gastrointestinal diseases. Its key commercial product is XPHOZAH® (tenapanor), a novel mechanism therapy for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis. Ardelyx also develops treatments for Irritable Bowel Syndrome with Constipation (IBS-C), aiming to advance patient care through its portfolio of innovative therapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-02-22 22:56 English ZIP 6.7 KB
2024-02-22 22:56 English ZIP 6.8 KB
2024-02-22 22:40
10-K
English ZIP 2.9 MB
2024-02-22 22:04
8-K
English ZIP 121.1 KB
2024-02-13 22:58
SCHEDULE 13G
English ZIP 10.9 KB
2024-02-13 20:12 English ZIP 6.7 KB
2024-02-09 22:14 English ZIP 7.4 KB
2024-02-08 22:32 English ZIP 7.4 KB
2024-01-31 22:25 English ZIP 17.6 KB
2024-01-26 22:23 English ZIP 13.5 KB
2024-01-18 22:39
FORM 4
English ZIP 7.6 KB
2024-01-18 22:38
FORM 4
English ZIP 7.9 KB
2024-01-18 22:37
FORM 4
English ZIP 7.5 KB
2024-01-18 22:36
FORM 4
English ZIP 7.6 KB
2024-01-18 22:35
FORM 4
English ZIP 7.9 KB

Automate Your Workflow. Get a real-time feed of all ARDELYX, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ARDELYX, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ARDELYX, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.